Canopy-1: Phase 3 Study of Canakinumab/Placebo

dc.contributorSistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP
dc.contributor.authorFELIP, E.
dc.contributor.authorJR, G. Castro
dc.contributor.authorGREYSTOKE, A.
dc.contributor.authorSOLOMON, B.
dc.contributor.authorTAN, D. S. W.
dc.contributor.authorGROHE, C.
dc.contributor.authorPASSOS, V. Q.
dc.contributor.authorDEUDON, S.
dc.contributor.authorLOUVEAU, A. L.
dc.contributor.authorARTICUS, K.
dc.contributor.authorJOHNSON, B.
dc.date.accessioned2021-01-25T19:23:12Z
dc.date.available2021-01-25T19:23:12Z
dc.date.issued2020
dc.description.indexMEDLINEeng
dc.identifier.citationPNEUMOLOGIE, v.74, suppl.1, p.S16-S17, 2020
dc.identifier.doi10.1055/s-0039-3403093
dc.identifier.eissn1438-8790
dc.identifier.issn0934-8387
dc.identifier.urihttps://observatorio.fm.usp.br/handle/OPI/38813
dc.language.isoeng
dc.publisherGEORG THIEME VERLAG KGeng
dc.relation.ispartofPneumologie
dc.rightsrestrictedAccesseng
dc.rights.holderCopyright GEORG THIEME VERLAG KGeng
dc.subject.wosRespiratory Systemeng
dc.titleCanopy-1: Phase 3 Study of Canakinumab/Placeboeng
dc.typeconferenceObjecteng
dc.type.categorymeeting abstracteng
dc.type.versionpublishedVersioneng
dspace.entity.typePublication
hcfmusp.affiliation.countryInglaterra
hcfmusp.affiliation.countryAustrália
hcfmusp.affiliation.countrySingapura
hcfmusp.affiliation.countryAlemanha
hcfmusp.affiliation.countryEstados Unidos
hcfmusp.affiliation.countrySuíça
hcfmusp.affiliation.countryFrança
hcfmusp.affiliation.countryEspanha
hcfmusp.affiliation.countryisoes
hcfmusp.affiliation.countryisogb
hcfmusp.affiliation.countryisoau
hcfmusp.affiliation.countryisosg
hcfmusp.affiliation.countryisode
hcfmusp.affiliation.countryisous
hcfmusp.affiliation.countryisoch
hcfmusp.affiliation.countryisofr
hcfmusp.author.externalFELIP, E.:Vall Dhebron Inst Oncol, Barcelona, Spain
hcfmusp.author.externalGREYSTOKE, A.:Newcastle Univ, Newcastle Upon Tyne, Tyne & Wear, England
hcfmusp.author.externalSOLOMON, B.:Peter Maccallum Canc Ctr Melbourne, Melbourne, Vic, Australia
hcfmusp.author.externalTAN, D. S. W.:Natl Canc Ctr Singapore, Singapore, Singapore
hcfmusp.author.externalGROHE, C.:Evangel Lungenklin Johannesstift Diakonie, Berlin, Germany
hcfmusp.author.externalPASSOS, V. Q.:Novartis Pharmaceut, E Hanover, NJ USA
hcfmusp.author.externalDEUDON, S.:Novartis Pharma AG, Basel, Switzerland
hcfmusp.author.externalLOUVEAU, A. L.:Novartis Pharma Sas, Rueil Malmaison, France
hcfmusp.author.externalARTICUS, K.:Novartis Pharma GmbH, Nurnberg, Germany
hcfmusp.author.externalJOHNSON, B.:Dana Farber Canc Inst, Boston, MA 02115 USA
hcfmusp.contributor.author-fmusphcGILBERTO DE CASTRO JUNIOR
hcfmusp.description.beginpageS16
hcfmusp.description.endpageS17
hcfmusp.description.issuesuppl 1
hcfmusp.description.volume74
hcfmusp.origemWOS
hcfmusp.origem.wosWOS:000588631500036
hcfmusp.publisher.citySTUTTGARTeng
hcfmusp.publisher.countryGERMANYeng
relation.isAuthorOfPublication0df25c0f-1337-424e-b0f7-41d0fccb51fc
relation.isAuthorOfPublication.latestForDiscovery0df25c0f-1337-424e-b0f7-41d0fccb51fc
Arquivos